These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 22302104)

  • 21. Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement.
    Shu R; Bai D; Sheu T; He Y; Yang X; Xue C; He Y; Zhao M; Han X
    PLoS One; 2017; 12(1):e0167312. PubMed ID: 28081119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part I of IV parts: mechanisms of calcium transfer between blood and bone and their cellular basis: morphological and kinetic approaches to bone turnover.
    Parfitt AM
    Metabolism; 1976 Jul; 25(7):809-44. PubMed ID: 781470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteocyte signaling in bone.
    Schaffler MB; Kennedy OD
    Curr Osteoporos Rep; 2012 Jun; 10(2):118-25. PubMed ID: 22552701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Osteocyte as a Novel Key Player in Understanding Periodontitis Through its Expression of RANKL and Sclerostin: a Review.
    de Vries TJ; Huesa C
    Curr Osteoporos Rep; 2019 Jun; 17(3):116-121. PubMed ID: 30924022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Osteocyte: New Insights.
    Robling AG; Bonewald LF
    Annu Rev Physiol; 2020 Feb; 82():485-506. PubMed ID: 32040934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanical Regulation of the Maternal Skeleton during Reproduction and Lactation.
    Liu XS; Wang L; de Bakker CMJ; Lai X
    Curr Osteoporos Rep; 2019 Dec; 17(6):375-386. PubMed ID: 31755029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteocytes: The master cells in bone remodelling.
    Prideaux M; Findlay DM; Atkins GJ
    Curr Opin Pharmacol; 2016 Jun; 28():24-30. PubMed ID: 26927500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteoblast and osteocyte: games without frontiers.
    Capulli M; Paone R; Rucci N
    Arch Biochem Biophys; 2014 Nov; 561():3-12. PubMed ID: 24832390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular communications in bone homeostasis and repair.
    Nakahama K
    Cell Mol Life Sci; 2010 Dec; 67(23):4001-9. PubMed ID: 20694737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen receptor α in osteocytes regulates trabecular bone formation in female mice.
    Kondoh S; Inoue K; Igarashi K; Sugizaki H; Shirode-Fukuda Y; Inoue E; Yu T; Takeuchi JK; Kanno J; Bonewald LF; Imai Y
    Bone; 2014 Mar; 60():68-77. PubMed ID: 24333171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Osteocyte as the New Discovery of Therapeutic Options in Rare Bone Diseases.
    Pathak JL; Bravenboer N; Klein-Nulend J
    Front Endocrinol (Lausanne); 2020; 11():405. PubMed ID: 32733380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: the role of fibroblast growth factor 23.
    Sapir-Koren R; Livshits G
    Biofactors; 2014; 40(6):555-68. PubMed ID: 25352227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations.
    Kennedy OD; Herman BC; Laudier DM; Majeska RJ; Sun HB; Schaffler MB
    Bone; 2012 May; 50(5):1115-22. PubMed ID: 22342796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of bone mass and remodeling by PTH receptor signaling in osteocytes.
    O'Brien CA; Plotkin LI; Galli C; Goellner JJ; Gortazar AR; Allen MR; Robling AG; Bouxsein M; Schipani E; Turner CH; Jilka RL; Weinstein RS; Manolagas SC; Bellido T
    PLoS One; 2008 Aug; 3(8):e2942. PubMed ID: 18698360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Skeletal aging].
    Ikeda K
    Clin Calcium; 2013 Jan; 23(1):11-4. PubMed ID: 23268296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma.
    Delgado-Calle J; Anderson J; Cregor MD; Hiasa M; Chirgwin JM; Carlesso N; Yoneda T; Mohammad KS; Plotkin LI; Roodman GD; Bellido T
    Cancer Res; 2016 Mar; 76(5):1089-100. PubMed ID: 26833121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation.
    Poole KE; van Bezooijen RL; Loveridge N; Hamersma H; Papapoulos SE; Löwik CW; Reeve J
    FASEB J; 2005 Nov; 19(13):1842-4. PubMed ID: 16123173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone matrix mineralization and osteocyte lacunae characteristics in patients with chronic kidney disease - mineral bone disorder (CKD-MBD).
    Misof BM; Blouin S; Roschger P; Werzowa J; Klaushofer K; Lehmann G
    J Musculoskelet Neuronal Interact; 2019 Jun; 19(2):196-206. PubMed ID: 31186390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diet and Exercise: a Match Made in Bone.
    Willems HME; van den Heuvel EGHM; Schoemaker RJW; Klein-Nulend J; Bakker AD
    Curr Osteoporos Rep; 2017 Dec; 15(6):555-563. PubMed ID: 29098573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel in vitro microfluidic platform for osteocyte mechanotransduction studies.
    Xu L; Song X; Carroll G; You L
    Integr Biol (Camb); 2020 Dec; 12(12):303-310. PubMed ID: 33420790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.